SAN FRANCISCO, April 16, 2025 (GLOBE NEWSWIRE) -- Zynex, Inc. (NASDAQ: ZYXI), the Denver-based medical technology firm, is facing a deepening vortex of financial, regulatory and legal challenges, with RBC Capital Markets reportedly further reducing its outlook on the company’s stock. The company faces added pressure from a recently filed securities class action lawsuit, alleging the company made false and misleading statements regarding its revenue recognition practices and its relationship with Tricare, a ...